Manon M H Huibers1, Alison J Gareau2, Aryan Vink3, Rianne Kruit3, Hannah Feringa3, Johanna M T Beerthuijzen3, Erica Siera-de Koning3, Ton Peeters3, Nicolaas de Jonge4, Roel A de Weger3, Timothy D G Lee5. 1. Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: m.m.h.huibers@umcutrecht.nl. 2. Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada. 3. Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. 4. Department of Cardiology, University Medical Center Utrecht, Utretcht, The Netherlands. 5. Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.
Abstract
BACKGROUND: Cardiac allograft vasculopathy (CAV) is a multifactorial pathology limiting the survival of cardiac transplants. The etiology of CAV is unclear, but antibody-mediated and cellular-mediated responses have been implicated. We, and others, have observed ectopic lymphoid structures (ELS) surrounding epicardial coronary arteries with CAV. The potential contribution of these ELS to CAV has not been elucidated. METHODS: Epicardial coronary arteries were collected from 59 transplant patients at 2 centers and studied for ELS presence and composition using immunohistochemistry. The intima and ELS were isolated, and the expression of the genes involved in tertiary lymphoid organ (TLO) formation was measured by quantitative polymerase chain reaction. RESULTS: ELS presence was related to survival after transplantation (p = 0.013) and histologic composition of CAV (p < 0.001). ELS contain B and T lymphocytes, macrophages, and antibody-producing (immunoglobulin [Ig] M and/or IgG) plasma cells. A sub-population of B lymphocytes appeared to be cluster of differentiation (CD)20(+)CD27(+) memory B lymphocytes. The messenger RNA expression of TLO markers (lymphotoxin-β, and chemokine [C-C motif] ligand 19 and 21) was significantly higher in ELS than in the neointimal lesions. The ELS observed in this study exhibited some TLO markers but did not exhibit the distinct areas rich in B and T lymphocytes that are normally found in classic TLOs. CONCLUSIONS: The cellular composition of the ELS differs from the cellular infiltrate in CAV intimal lesions. The presence of memory B lymphocytes and plasma producing IgM and IgG cells suggests that ELS are related to local antibody production, potentially contributing to antibody-mediated CAV. ELS associated with coronary vessels containing CAV show features of underdeveloped TLOs; classic TLOs may not develop due to patient immunosuppression.
BACKGROUND:Cardiac allograft vasculopathy (CAV) is a multifactorial pathology limiting the survival of cardiac transplants. The etiology of CAV is unclear, but antibody-mediated and cellular-mediated responses have been implicated. We, and others, have observed ectopic lymphoid structures (ELS) surrounding epicardial coronary arteries with CAV. The potential contribution of these ELS to CAV has not been elucidated. METHODS: Epicardial coronary arteries were collected from 59 transplant patients at 2 centers and studied for ELS presence and composition using immunohistochemistry. The intima and ELS were isolated, and the expression of the genes involved in tertiary lymphoid organ (TLO) formation was measured by quantitative polymerase chain reaction. RESULTS:ELS presence was related to survival after transplantation (p = 0.013) and histologic composition of CAV (p < 0.001). ELS contain B and T lymphocytes, macrophages, and antibody-producing (immunoglobulin [Ig] M and/or IgG) plasma cells. A sub-population of B lymphocytes appeared to be cluster of differentiation (CD)20(+)CD27(+) memory B lymphocytes. The messenger RNA expression of TLO markers (lymphotoxin-β, and chemokine [C-C motif] ligand 19 and 21) was significantly higher in ELS than in the neointimal lesions. The ELS observed in this study exhibited some TLO markers but did not exhibit the distinct areas rich in B and T lymphocytes that are normally found in classic TLOs. CONCLUSIONS: The cellular composition of the ELS differs from the cellular infiltrate in CAV intimal lesions. The presence of memory B lymphocytes and plasma producing IgM and IgG cells suggests that ELS are related to local antibody production, potentially contributing to antibody-mediated CAV. ELS associated with coronary vessels containing CAV show features of underdeveloped TLOs; classic TLOs may not develop due to patient immunosuppression.
Authors: Wenjun Li; Jason M Gauthier; Ryuji Higashikubo; Hsi-Min Hsiao; Satona Tanaka; Linh Vuong; Jon H Ritter; Alice Y Tong; Brian W Wong; Ramsey R Hachem; Varun Puri; Ankit Bharat; Alexander S Krupnick; Chyi S Hsieh; William M Baldwin; Francine L Kelly; Scott M Palmer; Andrew E Gelman; Daniel Kreisel Journal: J Clin Invest Date: 2018-12-18 Impact factor: 14.808
Authors: Carolina Moore; Baoshan Gao; Krishna M Roskin; Elena-Rodica M Vasilescu; Linda Addonizio; Michael M Givertz; Joren C Madsen; Emmanuel Zorn Journal: Am J Transplant Date: 2019-12-27 Impact factor: 8.086
Authors: Debanjana Chatterjee; Carolina Moore; Baoshan Gao; Kevin J Clerkin; Sarah B See; David Shaked; Kortney Rogers; Sarah Nunez; Yokarla Veras; Linda Addonizio; Michael M Givertz; Yoshifumi Naka; Donna Mancini; Rodica Vasilescu; Charles Marboe; Susan Restaino; Joren C Madsen; Emmanuel Zorn Journal: J Heart Lung Transplant Date: 2017-09-28 Impact factor: 10.247
Authors: Benjamin S Mantell; Hector Cordero; Sarah B See; Kevin J Clerkin; Rodica Vasilescu; Charles C Marboe; Yoshifumi Naka; Susan Restaino; Paolo C Colombo; Linda J Addonizio; Maryjane A Farr; Emmanuel Zorn Journal: J Heart Lung Transplant Date: 2021-07-08 Impact factor: 10.247
Authors: Marlena V Habal; April M I Miller; Samhita Rao; Sijie Lin; Aleksandar Obradovic; Mohsen Khosravi-Maharlooei; Sarah B See; Poulomi Roy; Ronzon Shihab; Siu-Hong Ho; Charles C Marboe; Yoshifumi Naka; Koji Takeda; Susan Restaino; Arnold Han; Donna Mancini; Michael Givertz; Joren C Madsen; Megan Sykes; Linda J Addonizio; Maryjane A Farr; Emmanuel Zorn Journal: Am J Transplant Date: 2020-10-26 Impact factor: 8.086